Search results

Technologies 1

• CogniXense for Rare Disease Drug Discovery
  Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome.

News 28

View all

• Translation News
  
  CRISPR’s Impact, Today
  October 21, 2024
• Press Release
  
  Advancing precision diagnostics at the patient point-of-care
  February 8, 2024
• Translation News
  
  Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
  October 17, 2022

Multimedia 2

• 

  Audio/Podcast
  Xenotransplantation – The Naked Scientists Podcast with George Church
  Amidst the aftermath of COVID-19 waiting lists continue to grow for those in need of an organ transplant, whilst simultaneously in an American surgery a man receives the heart of a pig. Animal donors may be the answer to our shortage of available organs, but the procedure isn’t quite ready to become common place. Take...

• 

  Video/Animation
  CRISPR-Cas: Molecular Recording
  In this video, Wyss Institute and Harvard Medical School researchers George Church and Seth Shipman explain how they engineered a new CRISPR system-based technology that enables the chronological recording of digital information, like that representing still and moving images, in living bacteria. Credit: Wyss Institute at Harvard University